|
COG5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.226100E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.436640E-03 |
| Normal-vs-Stage2 |
8.382400E-02 |
| Normal-vs-Stage3 |
7.72860000000097E-05 |
| Normal-vs-Stage4 |
2.015600E-03 |
| Stage1-vs-Stage2 |
5.288000E-01 |
| Stage1-vs-Stage3 |
8.015600E-02 |
| Stage1-vs-Stage4 |
3.722800E-01 |
| Stage2-vs-Stage3 |
1.040240E-01 |
| Stage2-vs-Stage4 |
2.738400E-01 |
| Stage3-vs-Stage4 |
5.852200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.781640E-03 |
| Normal-vs-AfricanAmerican |
4.19660000083866E-08 |
| Normal-vs-Asian |
4.744800E-01 |
| Caucasian-vs-AfricanAmerican |
1.612990E-04 |
| Caucasian-vs-Asian |
6.479600E-01 |
| AfricanAmerican-vs-Asian |
4.002200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.407900E-04 |
| Normal-vs-Female |
5.757900E-04 |
| Male-vs-Female |
8.560800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.501760E-02 |
| Normal-vs-Age(41-60Yrs) |
1.021270E-03 |
| Normal-vs-Age(61-80Yrs) |
1.423450E-03 |
| Normal-vs-Age(81-100Yrs) |
6.003400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.258000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.972200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.116200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.163000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.262600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.062200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.748350E-01 |
| Normal-vs-Grade 2 |
7.320200E-03 |
| Normal-vs-Grade 3 |
1.358960E-04 |
| Normal-vs-Grade 4 |
5.986800E-04 |
| Grade 1-vs-Grade 2 |
9.512600E-01 |
| Grade 1-vs-Grade 3 |
5.404600E-01 |
| Grade 1-vs-Grade 4 |
4.396600E-01 |
| Grade 2-vs-Grade 3 |
1.288640E-01 |
| Grade 2-vs-Grade 4 |
1.060630E-01 |
| Grade 3-vs-Grade 4 |
5.663600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.315500E-02 |
| Normal-vs-ccB subtype |
1.557510E-03 |
| ccA subtype-vs-ccB subtype |
5.194100E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.083800E-03 |
| Normal-vs-N1 |
3.180600E-01 |
| N0-vs-N1 |
9.759000E-01 |
|
|
